ETF Holdings Breakdown of LYEL

Stock NameLyell Immunopharma Inc
TickerLYEL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS55083R1041

LYEL institutional holdings

The adjusted close for LYEL on 2025-11-11 was 17.25

The following institutional investment holdings of LYEL have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-11-11 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 12,354USD 213,107 17.25  
2025-11-11 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 12,354USD 213,107 -2.5% 17.25  
Total =24,708 USD 426,214
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with LYEL

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Down 29.3% in August
Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report) saw a large decline in short interest in the month of August. As of August 15th, there was short interest totaling 133,000 shares, a decline of 29.3% from the July 31st total of 188,200 shares. Currently, 2.4% of the company’s shares are short sold. Based on an […] - 2025-09-10 03:11:06
Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded shares of Lyell Immunopharma (NASDAQ:LYEL – Free Report) from a sell rating to a hold rating in a research report sent to investors on Monday morning. Separately, HC Wainwright reaffirmed a “neutral” rating and set a $10.00 price target on shares of Lyell Immunopharma in a research note on Tuesday, June […] - 2025-09-02 03:06:55
Lyell Immunopharma (NASDAQ:LYEL) Lowered to Strong Sell Rating by Wall Street Zen
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “strong sell” rating in a report issued on Saturday. Separately, HC Wainwright restated a “neutral” rating and set a $10.00 target price on shares of Lyell Immunopharma in a research report on Tuesday, […] - 2025-08-18 04:46:49
Lyell Immunopharma (NASDAQ:LYEL) Trading Down 5.9% – Here’s Why
Lyell Immunopharma, Inc. (NASDAQ:LYEL – Get Free Report)’s stock price fell 5.9% during trading on Tuesday . The stock traded as low as $9.02 and last traded at $9.10. 36,808 shares were traded during mid-day trading, a decline of 49% from the average session volume of 72,562 shares. The stock had previously closed at $9.67. […] - 2025-07-16 04:42:52
Lyell Immunopharma (NASDAQ:LYEL) Stock Price Expected to Rise, HC Wainwright Analyst Says
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report) had its price target boosted by research analysts at HC Wainwright to $10.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 7.64% from the […] - 2025-06-26 02:48:49
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC raised its position in Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 2.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 4,137,264 shares of the company’s stock after acquiring an additional 117,303 shares during the quarter. Geode Capital Management LLC’s holdings in Lyell Immunopharma were worth $2,648,000 as of […] - 2025-04-29 04:30:48

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.